Markets › United States › NAS › BNTC

Benitec Biopharma Inc

NAS:BNTCHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$8.36+3.08%At closeAt close · Tue 20 Oct · ≈ AED 30.70 · Market cap $291.62M · Next earnings Mon 16 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	−108.5%	87.7%	100.0%	—	—	—	—	—
Operating margin	−23,044.1%	−24,457.5%	−25,441.3%	—	—	—	—	—
Net margin	−23,528.8%	−24,942.5%	−26,082.7%	—	—	—	—	—
EBITDA margin	−22,800.0%	−24,361.6%	−24,933.3%	—	—	—	—	—
Return on equity	−69.4%	−631.8%	−9,684.2%	−46.0%	−39.0%	−25.7%	−39.0%	−13.2 pts
Return on assets	−64.9%	−304.8%	−438.2%	−41.7%	−38.1%	−24.9%	−38.1%	−13.1 pts
Return on capital employed	−67.9%	−518.9%	−3,926.1%	−47.6%	−42.7%	−28.9%	—	—
Debt / equity	0.0×	0.3×	2.8×	0.0×	0.0×	0.0×	0.0×	+102.7%
Debt / assets	1.0%	13.6%	12.5%	0.5%	0.9%	0.4%	—	—
Interest coverage	−2,266.0×	−557.9×	−578.2×	0.0×	12.7×	0.0×	—	—
Current ratio	15.1×	1.9×	0.9×	10.5×	54.7×	34.0×	54.7×	+60.8%
Quick ratio	15.1×	1.9×	0.9×	10.5×	54.7×	34.0×	—	—
Cash ratio	14.4×	1.6×	0.6×	10.3×	54.2×	33.7×	54.2×	+61.1%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	2.4×	24.3×	1.4×	0.0×	0.0×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—